10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001121781-13-000294`
Period End Date	20130630
Filing Date	20130814
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	gthp-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 72 Cash Flow Statement 58

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at June 30, 2013 and December 31, 2012, respectively	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$44.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at June 30, 2013 and December 31, 2012, respectively	`AccountsReceivableNet`	$177.00K	USD	Point-in-time
Inventory, net of reserves of $52, at June 30, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Inventory, net of reserves of $52, at June 30, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$607.00K	USD	Point-in-time
Convertible Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$115.00K	USD	Point-in-time
Convertible Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Convertible Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.88M	USD	Point-in-time
Convertible Preferred stock, issued	`PreferredStockSharesIssued`	2,527.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Convertible Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred stock, outstanding	`PreferredStockSharesOutstanding`	2,527.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$380.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.52M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.40M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	66,073.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62,282.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62,282.00	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$9.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	66,073.00	shares	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$101.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	-	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$419.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$986.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$520.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$4.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.62M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Warrants, at fair value	`WarrantsAndRightsOutstanding`	-	USD	Point-in-time
Warrants, at fair value	`WarrantsAndRightsOutstanding`	$873.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$157.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Total long-term	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total long-term	`LiabilitiesNoncurrent`	$1.03M	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$2.65M	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$2.35M	USD	Point-in-time
COMMITMENTS & CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS & CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 2,527 and zero shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively (liquidation preference of $2.5 million as of June 30, 2013)	`PreferredStockValue`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 2,527 and zero shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively (liquidation preference of $2.5 million as of June 30, 2013)	`PreferredStockValue`	$1.34M	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 66,073 and 62,282 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 66,073 and 62,282 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$62.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$97.31M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-96.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.40M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$1.63M	USD	2 Qtrs
Contract and grant revenue	`Revenues`	$222.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$389.00K	USD	2 Qtrs
Contract and grant revenue	`Revenues`	$915.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$29.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$116.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$248.00K	USD	2 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$29.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$75.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$277.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$75.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$119.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-29.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-46.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-3.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-46.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.61M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$898.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$834.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$69.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$139.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$195.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$359.00K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.97M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.05M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.98M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$931.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.02M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.98M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.96M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.73M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.14M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.62M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.74M	USD	1 Quarter
OTHER INCOME	`OtherIncome`	-	USD	2 Qtrs
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$75.00K	USD	2 Qtrs
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$19.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$9.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$24.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$36.00K	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-2.18M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-1.17M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-1.75M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-3.56M	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.18M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.75M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`DividendsPreferredStock`	$1.17M	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`DividendsPreferredStock`	-	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`DividendsPreferredStock`	$1.17M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`DividendsPreferredStock`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.17M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.74M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.18M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.92M	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	65,675.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	54,077.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	53,274.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	64,678.00	shares	2 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	2 Qtrs
Bad debt expense (recovery)	`BadDebtRecovery`	$-8.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$163.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$227.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$350.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$569.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$61.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-94.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-14.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-76.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$15.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$83.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-33.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$221.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-36.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$319.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-59.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$74.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$165.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-50.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.09M	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$792.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.09M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.77M	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$101.00K	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$351.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-351.00K	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromWarrantExercises`	$2.21M	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromStockOptionsExercised`	$1.83M	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromStockOptionsExercised`	$690.00K	USD	2 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$11.00K	USD	2 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$237.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$679.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.81M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-760.00K	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$936.00K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.44M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$11.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$9.00K	USD	2 Qtrs
Deemed dividends in the form of convertible warrants into common stock	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	2 Qtrs
Deemed dividends in the form of convertible warrants into common stock	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$231.00K	USD	2 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$1.17M	USD	2 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	-	USD	2 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	2 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.